Kensey Nash Corporation is a medical device company primarily focused in the field of regenerative medicine, which is the application of devices, materials and other therapies to help repair damaged or diseased tissues. The Company has a range of products, which are sold through strategic partners in multiple large medical markets, including cardiology, orthopaedic, sports medicine, spinal and general surgery. It also has an ongoing development and manufacturing program for products in the endovascular market. During the fiscal year ended June 30, 2010 (fiscal 2010), the Company manufactured and sold over 4.5 million resorbable product units representing approximately 230 commercialized products, to strategic partners and customers. In January 2011, the Company acquired Nerites Corporation. In June 2012, Koninklijke DSM NV acquired the Company.